Spago Nanomedical AB Asset Resilience Ratio

Latest as of December 2016: 54.03%

Spago Nanomedical AB asset resilience ratio. Spago Nanomedical AB (SPAGO) has an Asset Resilience Ratio of 54.03% as of December 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SPAGO days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Skr43.26 Million

≈ $4.66 Million USD Cash + Short-term Investments

Total Assets

Skr80.06 Million

≈ $8.62 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Spago Nanomedical AB (None–None)

Asset resilience ratio of Spago Nanomedical AB from None to None. This chart shows how Spago Nanomedical AB's Asset Resilience Ratio has changed over time. Read SPAGO current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Spago Nanomedical AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Spago Nanomedical AB total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr43.26 Million	54.03%
Total Liquid Assets	Skr43.26 Million	54.03%

Asset Resilience Insights

Very High Liquidity: Spago Nanomedical AB maintains exceptional liquid asset reserves at 54.03% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Spago Nanomedical AB Industry Peers by Asset Resilience Ratio

Compare Spago Nanomedical AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Spago Nanomedical AB Asset Resilience Ratio by Year (None–None)

Spago Nanomedical AB asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Spago Nanomedical AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Spago Nanomedical AB

ST:SPAGO Sweden Biotechnology

Market Cap

$2.39 Million

Skr22.23 Million SEK

Market Cap Rank

#29813 Global

#673 in Sweden

Share Price

Skr0.03

Change (1 day)

-2.33%

52-Week Range

Skr0.03 - Skr0.14

All Time High

Skr19.04